Articles On Telix Pharmaceuticals (ASX:TLX)

Australian shares closed higher on Tuesday, with the S&P/ASX 200 advancing 0.4% to 7664.1 points, supported by gains in lithium miners, while investors exercised caution ahead of the US Federal Reserve's policy meeting for insights into...

It was a mildly disappointing Wednesday for ASX investors today, with the S&P/ASX 200 Index (ASX: XJO) recording a slight loss. After spending most of the day in green territ...

  Companies discussed include: Telix Pharmaceuticals (ASX:TLX)Bank of Queensland (ASX:BOQ)MAAS Group Holdings (ASX:MGH)

One ASX healthcare stock is clocking a new record price today while the S&P/ASX 200 Index (ASX: XJO) struggles to keep its head above water. The Aussie share market is flailing this afternoon after the Australian Bureau of Statistic...

In the dynamic landscape of investing, uncovering hidden gems amidst the sea of opportunities often requires a keen eye for potential change and growth catalysts. Telix Pharmaceuticals (ASX:TLX), despite its relatively short tenure on the A...

ASX health stock fall in past five days in line with broader markets as economic and geopolitical factors weigh heavily ResMed falls as Eli Lily reports positive Phase 3 results of weight-loss drug in obese people with obstructive sleep ap...

It turned out to be a day of high relief for ASX investors, with the S&P/ASX 200 Index (ASX: XJO) finally recording a positive session after five days of falls in a row. By the c...

The S&P/ASX 200 Index (ASX: XJO) is back on form and pushing higher on Thursday. In afternoon trade, the benchmark index is up 0.6% to 7,650.2 points. Four ASX shares that are rising more than most today are listed below. Here's why th...

The Telix Pharmaceuticals Ltd (ASX: TLX) share price is taking off on Thursday morning. At the time of writing, the radiopharmaceuticals company's shares are up 15% to a record high of $14.46. Why is the Telix share price rocketing? Investo...

Telix Pharmaceuticals (ASX:TLX) has reported an 18 per cent increase in revenue for the first three months of the calendar year 2024.

On Wednesday, the S&P/ASX 200 Index (ASX: XJO) fought hard but fell short at the final hurdle and slipped into the red. The benchmark index fell slightly to 7,605.6 points. Will the market be able to bounce back from this on Thursday?...

MELBOURNE, Australia, April 17, 2024 /PRNewswire/ — Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today provides an update on its revenue and operational performance for the quarter ended 31 March 2024 (Q1 2024). Summary...

After shedding nearly double what futures had predicted, the ASX200 closed the day 1.8 per cent down. At one stage the ASX was on track for its worst day in 13 months and at the close, real estate, consumer stocks and mining were all lickin...

The ASX200 has shed nearly double what futures predicted, trading down 2.05% All 11 sectors are in the red. Discretionary has lost the most so far, down 2.6%. Real Estate follows, down 2.305%, while in Canberra supermarket executives saw...

The S&P/ASX 200 Index (ASX: XJO) is having a day to forget on Tuesday. In afternoon trade, the benchmark index is down a very disappointing 2.1% to 7,586.6 points. Four ASX shares that are avoiding the market selloff today are listed be...

Telix Pharmaceuticals (ASX:TLX) has been granted Fast Track designation by The United States Food and Drug Administration (FDA) for its brain cancer imaging software; TLX101-CDx (also known as Pixclara™). This Fast Track designation is s...

Telix Pharmaceuticals Ltd (ASX: TLX) shares are rising on Tuesday. In morning trade, the ASX 200 healthcare stock is up 1.5% to $13.08. Why is the ASX 200 healthcare stock pushing higher? Investors have been buying the company's shares afte...

The US FDA has granted fast-track designation to Telix Pharmaceuticals (ASX:TLX) investigational glioma imaging product Pixclara (TLX101-CDx).

The pain’s set to intensify today, with a 0.8 per cent fall predicted on the ASX200. Retail sales figures in the US came in better than expected, and with fears the Israel, Iran conflict could escalate, gold rose and so did bond yields....

FDA Fast Track designation granted for TLX101-CDx for glioma (brain cancer) imaging Collaboration agreement announced for joint development and commercialisation with UCSF PharmaLogic announced as commercial manufacturing and pharmacy...

There could be some big returns on offer in the healthcare sector for Australian investors according to analysts. For example, the three ASX 200 healthcare stocks listed below have all been named as buys by analysts and tipped to deliver do...

On Thursday, the S&P/ASX 200 Index (ASX: XJO) had a tough session and dropped into the red. The benchmark index fell 0.45% to 7,813.6 points. Will the market be able to bounce back from this on Friday and end the week on a high? Here...

The ASX200 is up nearly half a per cent – slightly beating futures predictions – with materials leading the charge into greener territory. Materials were up nearly 2 per cent in-mid-day trading with real estate and communications both d...

Telix Pharmaceuticals (ASX:TLX) has acquired one of its service suppliers – IsoTherapeutics Group – in a deal worth more than A$20 million. IsoTherapeutics, a commercial-stage entity, specializes in providing radiochemistry and bioconju...

The ASX200 is set to continue its upward run today, with futures pointing to a .41 per cent lift. US treasury yields climbed to the highest point in months on strong data, seeing the S&P500 and Dow Jones close a touch lower, while th...

The ASX200 has closed down .56 of a per cent with IT down 1.4 per cent and in the red for a second straight day, materials slumping 0.8 per cent and real estate shedding .61 per cent. Coming into sharp focus today were OncoSil Medical, T...

The S&P/ASX 200 Index (ASX: XJO)  wrapped up the shorter trading week on a sour note this Friday. After a fairly wild week, the index couldn't close in the green, giving investors a red...

The S&P/ASX 200 Index (ASX: XJO) is having a disappointing finish to the week. In afternoon trade, the benchmark index is down 0.7% to 7,760.9 points. Four ASX shares that are not letting that hold them back are listed below. Here's w...

Everyone remembers their first time. If you have never done it before, buying ASX shares can be a scary experience. You don't know whether you will lose money. You feel like you don't have as much knowledge as the veterans. You're concerne...

It was a very strong day indeed for the S&P/ASX 200 Index (ASX: XJO) this Thursday. After the disappointing session yesterday, it was back to the...

The S&P/ASX 200 Index (ASX: XJO) had a negative session this Wednesday, falling after an initially strong start to the week. Despite an early surge...

MELBOURNE, Australia and DRESDEN, Germany, March 19, 2024 /PRNewswire/ — Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces that it has entered into an agreement to commercially partner the QDOSE® dosimetry soft...

The S&P/ASX 200 Index (ASX: XJO) had a wild start to this week's trading but overcame plenty of pessimism throughout the trading day to finish up in...

It's been a horror end to the trading week for the S&P/ASX 200 Index (ASX: XJO) this Friday. The ASX 200 fell sharply at market open, dropping as muc...

With the S&P/ASX 200 Index (ASX: XJO) rocketing more than 14% since the start of November, stock selection has now become critical. After all, you don't want to be buying an ASX stock after it has already become expensive. Every cent y...

ASX growth shares that are soaring rapidly are obviously exciting and rewarding to own. But, of course, one must always remember with reward comes risk. Not every hyper-growth stock you buy will end up a 10-bagger. Probably not even the ma...

MELBOURNE, Australia, March 12, 2024 /PRNewswire/ — Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) is pleased to announce the appointment of Dr. Darren Patti as Group Chief Operating Officer (COO), effective 11 March 2024....

Telix Pharmaceuticals Ltd (ASX: TLX) shares are up approximately 75% over the last 12 months. Investors have been buying the ASX 200 biotech stock after it reported explosive growth in FY 2023 last month. The company delivered a 214% incr...

On Friday, the S&P/ASX 200 Index (ASX: XJO) ended the week at a record high close. The benchmark index rose 1.1% to 7,847 points. Will the market be able to build on this on Monday? Here are five things to watch: ASX 200 expected to...

The S&P/ASX 200 Index (ASX: XJO) has concluded the week's trading on a decidedly high note. Literally. For today, the ASX 200 minted a fresh new all-time h...

Just $9,000 could start your journey into the delicious world of passive income. In fact, I reckon you're in with a shot of generating a perpetual monthly payment of $500 if you play your cards right. Don't believe me? Check out this hypot...

The ASX 200 traded sideways on Tuesday, closing the day flattish as gains in healthcare stocks were offset by losses in other sectors. Source: Market Index  Healthcare gained after the Albanese government approved an increase in private hea...

Australian biopharmaceutical company Telix Pharmaceuticals (ASX: TLX) is set to acquire Canadian radioisotope technology firm ARTMS Inc in a $125.9 million deal designed to boost its supply chain and production capacity. The deal will inclu...

Telix (ASX:TLX) will acquire radioisotope production technology firm ARTMS, its advanced cyclotron-based isotope production platform, manufacturing plant and a stockpile of ultra-pure rare metals required for consumable target produ...

MELBOURNE, Australia, March 5, 2024 /PRNewswire/ — Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces it has entered into an agreement to acquire radioisotope production technology firm ARTMS Inc. (ARTMS), its a...

The S&P/ASX 200 Index (ASX: XJO) snatched victory from the jaws of defeat today, recording a mild rise. After spending the whole day in red territory, the ASX 200...

Telix Pharmaceuticals strengthens its global presence by acquiring Texas-based IsoTherapeutics IsoTherapeutics, established in 2005, specialises in radiochemistry Telix’s strategic move aims to enhance in-house drug development, redu...

Telix (ASX:TLX) has announced total group revenue of $502.5 million for the 12 months to the end of December, up 214 per cent on the previous year.

MELBOURNE, Australia, Feb. 27, 2024 /PRNewswire/ — Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces it has entered into an agreement to acquire IsoTherapeutics Group, LLC (IsoTherapeutics), a specialty radioph...

Welcome to the FNArena Corporate Results Monitor. Today's Reports: ((29M)) - 29Metals ((AX1)) - Accent Group ((AMA)) - AMA Group ((APA)) - APA Group ((LTM)) - Arcadium Lithium ((A1N)) - ARN Media ((ABB)) - Aussie Broadband ((ASB)) - Austa...